Meet Our Key Advisors

No leaders found in this category.

News and Resources

CPRIT Provides $10.8M Grant to Advance B...

The oncolytic virus Delta-24-RGD elicits...

Oncolytic Adenovirus and Tumor-Targeting...

Localized Treatment with Oncolytic Adeno...

Preclinical Characterization of the Anti...

Examination of the Therapeutic Potential...

Human Bone Marrow–Derived Mesenchymal ...

Delta-24-RGD Oncolytic Adenovirus Elicit...

Preclinical Evaluation of Sequential Com...

A Phase I Study of a Tropism-Modified Co...

Phase I Trial of DNX-2401 for Diffuse In...

Oncolytic Virotherapy for Malignant Glio...

Phase I Study of DNX-2401 (Delta-24-RGD)...

Infectious enthusiasm...

DNX-2401 wins $2 million FDA grant for c...

Potential of oncolytic viruses back on i...

A cold virus could extend lives of some ...

Smart bomb virus shows promise as brain ...

DNX-2401 Demonstrates “Dramatic&#8...

Re-engineered Cold Virus Increases Brain...

Early Trial Shows ‘Smart Bomb&#821...

The Deadly Viruses Being Used To Combat ...

Treating diffuse midline gliomas with an...

The Common Cold as Cure?...

Convergence of technology, immunotherapy...
See More Content